RecruitingNot ApplicableNCT07508592

Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery

A Prospective Study on the Usability and Clinical Outcomes of the SEGER IDEA™ Device for Enterotomy Closure


Sponsor

Seger Surgical Solutions

Enrollment

10 participants

Start Date

Feb 17, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a first-in-human feasibility study designed to evaluate the safety and performance of the SEGER device in patients undergoing elective laparoscopic gastrointestinal surgery requiring intracorporeal anastomosis. The study will include patients undergoing procedures such as small bowel-small bowel and colorectal anastomoses. The SEGER device is intended to facilitate closure of enterotomies and support intracorporeal anastomosis during minimally invasive surgery. The primary objective of the study is to assess the safety of the device and its performance during surgery. Secondary objectives include evaluation of technical success, intraoperative usability, and early postoperative outcomes.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria7

  • Adults (e.g., age 18-80) who are candidates for
  • Laparoscopic ileocolic resection
  • Laparoscopic right hemicolectomy
  • Elective laparoscopic small bowel-small bowel anastomosis (including jejuno-jejunostomy and ileo-ileal anastomosis) performed as part of gastric bypass surgery (a maximum of 40% of the total enrolled population may consist of bariatric (gastric bypass) cases).
  • The surgeon has determined that an intracorporeal anastomosis is appropriate for the case,
  • The patient is able to provide informed consent and is willing to participate in the study, and
  • The patient has no condition that would preclude safe use of the device.

Exclusion Criteria5

  • Patients in emergency surgery situations (urgent cases where study enrollment and the careful use of a new device are not feasible),
  • Patients with extensive intra-abdominal adhesions or anatomical abnormalities that would make intracorporeal anastomosis technically impossible,
  • Patients with a known hypersensitivity to titanium or stainless steel (although rare, this relates to staple/anvil materials),
  • Pregnant patients.
  • Patients with severe uncontrolled coagulopathy or other high-risk medical conditions that, in the judgment of the investigator and surgical team, do not allow for a safe surgical procedure

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESEGER Device

The SEGER device is an investigational surgical device used during laparoscopic gastrointestinal procedures to facilitate intracorporeal closure of enterotomies and support small bowel anastomosis. The device is applied intraoperatively as part of the surgical workflow.


Locations(1)

Hospital Nacional Zacamil

San Salvador, El Salvador

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07508592


Related Trials